Abstract
OBJECTIVES:
To identify predictors of in-hospital mortality in patients with acute myocardial infarction undergoing pharmacoinvasive treatment.
METHODS:
This was an observational, prospective study that included 398 patients admitted to a tertiary center for percutaneous coronary intervention within 3 to 24 hours after thrombolysis with tenecteplase. ClinicalTrials.gov: NCT01791764
RESULTS:
The overall in-hospital mortality rate was 5.8%. Compared with patients who survived, patients who died were more likely to be older, have higher rates of diabetes and chronic renal failure, have a lower left ventricular ejection fraction, and demonstrate more evidence of heart failure (Killip class III or IV). Patients who died had significantly lower rates of successful thrombolysis (39% vs. 68%; p = 0.005) and final myocardial blush grade 3 (13.0% vs. 61.9%; p<0.0001). Based on the multivariate analysis, the Global Registry of Acute Coronary Events score (odds ratio 1.05, 95% confidence interval (CI) 1.02-1.09; p = 0.001), left ventricular ejection fraction (odds ratio 0.9, 95% CI 0.89-0.97; p = 0.001), and final myocardial blush grade of 0-2 (odds ratio 8.85, 95% CI 1.34-58.57; p = 0.02) were independent predictors of mortality.
CONCLUSIONS:
In this prospective study that evaluated patients with ST-segment elevation myocardial infarction treated by a pharmacoinvasive strategy, the in-hospital mortality rate was 5.8%. The Global Registry of Acute Coronary Events score, left ventricular ejection fraction, and myocardial blush were independent predictors of mortality in this high-risk group of acute coronary syndrome patients.
Myocardial Infarction; Mortality; Pharmacoinvasive Therapy
INTRODUCTION
Primary percutaneous coronary intervention (pPCI) is the standard of care reperfusion therapy for
patients with evolving ST-segment elevation myocardial infarction (STEMI) (11. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al.
ESC Guidelines for the management of acute myocardial infarction in patients presenting with
ST-segment elevation. Eur Heart J. 2012;33(20):2569-619.
2. Piegas LS, Feitosa G, Mattos LA, Nicolau JC, Rossi Neto JM, Timerman A, et al.
Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia sobre
Tratamento do Infarto agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras
Cardiol. 2009;93(6 supl.2):e179-e264.-33. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et
al. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary:
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510,
http://dx.doi.org/10.1016/j.jacc.2012.11.018.
http://dx.doi.org/10.1016/j.jacc.2012.11...
). Although individual centers have
performed pPCI for many years, a significant number of patients with STEMI either do not receive
this optimal treatment or do not receive it in a timely manner due to the small number of tertiary
care centers with an around-the-clock ('24/7') service. Large urban centers and rural
areas, where tertiary care hospitals are restricted to specific regions, are less likely to have the
capacity to deliver this treatment to the population as a whole (44. Boden WE, Eagle K, Granger CB. Reperfusion Strategies in Acute ST-Segment
Elevation Myocardial Infarction. A Comprehensive Review of Contemporary Management Options.
J Am Coll Cardiol. 2007;50(10):917-29,
http://dx.doi.org/10.1016/j.jacc.2007.04.084.
http://dx.doi.org/10.1016/j.jacc.2007.04...
).
Thus, a pharmacoinvasive treatment strategy has emerged as an alternative for STEMI patients admitted to primary care centers. A pharmacoinvasive strategy consists of the use of intravenous thrombolytic therapy in a primary care center followed by immediate transfer to a tertiary hospital, where early, systematic coronary angiography and percutaneous coronary angioplasty should be performed within 3 to 24 hours, even in cases of successful reperfusion (55. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;e574-e651.).
In Brazil, despite recent social and medical therapeutic advances, the number of acute myocardial
infarctions in the population still reaches 300,000 to 400,000 per year, with STEMI representing 30%
to 40% of all cases. Furthermore, mortality rates are still high outside major referral centers,
with an estimated 1 death for every 5 to 7 cases (66. Linha do Cuidado do Infarto Agudo do Miocárdio na Rede de Atenção
às Urgências [Path of Care of Acute Myocardial Infarction in Emergency Care Networks,
guidelines developed by The Brazilian Health Secretary]. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/protocolo_sindrome_coronaria.pdf.
(Accessed on December 20, 2012).
http://portal.saude.gov.br/portal/arquiv...
).
Therefore, we recently developed a public STEMI network based on a pharmacoinvasive treatment
strategy in the metropolitan area of São Paulo as a possible alternative to pPCI. In the
present study, we sought to evaluate the rate and predictors of in-hospital mortality in a large
population of STEMI patients who underwent pharmacoinvasive treatment.
METHODS
Patients and study protocol
Between November 2010 and October 2012, 567 patients with STEMI were transferred to a tertiary
hospital (Hospital São Paulo, Escola Paulista de Medicina at Federal University of São
Paulo) as part of a municipal primary care program for STEMI. The structured health care network for
patients with STEMI has been previously described in detail elsewhere (77. Caluza ACV, Barbosa AH, Gonçalves I, Oliveira CAL, Matos LN, Zeefried C, et
al. Rede de Infarto com Supradesnivelamento de ST: Sistematização em 205 Casos Diminui
Eventos Clínicos na Rede Pública [ST-Elevation Myocardial Infarction Network:
Systematization in 205 Cases Reduces Clinical Events in the Public Health Care System]. Arq
Bras Cardiol. 2012;99(5):1040-8, http://dx.doi.org/10.1590/S0066-782X2012005000100.
http://dx.doi.org/10.1590/S0066-782X2012...
). In brief, patients are first admitted to a primary emergency room facility or
rescued by the Emergency Mobile Healthcare Service (SAMU) at home and then referred to our tertiary
PCI center. Patients were either treated with thrombolysis or underwent pPCI as appropriate and
according to current guidelines (11. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al.
ESC Guidelines for the management of acute myocardial infarction in patients presenting with
ST-segment elevation. Eur Heart J. 2012;33(20):2569-619.
2. Piegas LS, Feitosa G, Mattos LA, Nicolau JC, Rossi Neto JM, Timerman A, et al.
Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia sobre
Tratamento do Infarto agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras
Cardiol. 2009;93(6 supl.2):e179-e264.-33. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et
al. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary:
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510,
http://dx.doi.org/10.1016/j.jacc.2012.11.018.
http://dx.doi.org/10.1016/j.jacc.2012.11...
). Those patients receiving thrombolysis were referred for an early invasive
coronary angiography procedure regardless of successful reperfusion 3 to 24 hours after thrombolysis
(i.e., elective or rescue PCI) according to clinical and electrocardiographic criteria. Coronary
angiographies were performed by femoral access, and only bare metal stents were used. After
excluding patients who did not receive thrombolysis, those who underwent pPCI, and those with no
acute myocardial infarction, 398 patients remained for the present analysis.
Study objective and definitions
The primary objective of this study was to evaluate the rate and predictors of in-hospital
mortality in a population of STEMI patients who underwent pharmacoinvasive treatment. Patients were
consecutively included and divided into two groups according to mortality (patients who died during
the index hospitalization from all causes and patients who survived) and compared according to their
clinical, angiographic, and procedural variables as appropriate. Demographic and clinical data were
entered into a database prospectively, and all quantitative coronary angiography data were analyzed
by one experienced interventional cardiologist. Thrombolysis in myocardial infarction (TIMI) flow
and blush grade were assessed as previously reported (88. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial.
Phase I findings. N Engl J Med. 1985;312(14):932-6.,99. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F.
Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for
acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.
Circulation. 1998;97(23):2302-6, http://dx.doi.org/10.1161/01.CIR.97.23.2302.
http://dx.doi.org/10.1161/01.CIR.97.23.2...
). Coronary artery disease (CAD) was defined as single- or
multi-vessel disease according to the number of epicardial arteries with at least 1 lesion measuring
≥70% of the diameter of stenosis.
Chronic renal failure was defined as creatinine clearance <60 mL/min, estimated by the
Cockcroft-Gault formula (1010. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum
creatinine. Nephron. 1976;16(1):31-41, http://dx.doi.org/10.1159/000180580.
http://dx.doi.org/10.1159/000180580...
). Anemia was defined as plasma
hemoglobin measuring less than 13 mg/dL for males or 12 mg/dL for females (1111. WHO. Hemoglobin concentrations for the diagnosis of anemia and assessment of
severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011
(WHO/NMH/NHD/MNM/11.1). Available at: http://www.who.int/vmnis/indicators/haemoglobin.pdf. (Accessed on December 20,
2012).
http://www.who.int/vmnis/indicators/haem...
). The Global Registry of Acute Coronary Events (GRACE) score (1212. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al.
Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med.
2003;163(19):2345-53, http://dx.doi.org/10.1001/archinte.163.19.2345.
http://dx.doi.org/10.1001/archinte.163.1...
) was calculated at admission, and the left ventricular ejection
fraction (LVEF) was determined by echocardiography during hospitalization. Successful thrombolysis
was defined as a culprit artery with TIMI flow grade 2-3 at the time of coronary angiography. Time
intervals between chest pain and the administration of Tenecteplase (TNK; pain-to-needle time) and
between the administration of TNK and coronary angiography (needle-to-balloon time) are expressed in
hours. This study was conducted in compliance with the ethical principles of the Helsinki
Declaration (2008), as well as local applicable laws and regulations. It was registered in
ClinicalTrials.gov with the identifier number NCT01791764.
Statistical analysis
Continuous variables are expressed as the mean and standard deviation, and categorical variables are expressed as absolute numbers and percentages. Fisher's exact test, Pearson's chi-square test, or Student's t-test were used when appropriate.
A multivariate logistic regression model was used to identify potential independent predictors of mortality. Odds ratios (ORs) and their respective confidence intervals (95% CIs) were used to quantify the effects. The variables included in the model were age, gender, hemoglobin level, diabetes mellitus, hypertension, current smoking status, chronic renal failure, GRACE score, Killip class, baseline and final TIMI flow, and final myocardial blush grade. SPSS® software version 20 (IBM, Armonk, NY, USA) was used for all analyses, and a final p value less than 0.05 was considered significant.
RESULTS
The study flowchart is shown in Figure 1. After excluding pPCI patients, patients without CAD, patients triaged to CABG, and patients treated with thrombolytics other than TNK, a total of 398 patients were selected for the current analysis. The mean pain-to-needle and needle-to-balloon times were 4.5±3.8 and 16.4±20.6 hours, respectively. Overall, the in-hospital mortality rate was 5.8% (compared with 6.5% of the entire population of 567 patients), and the mean GRACE score was 148.2±36.9. A comparison of demographic and clinical characteristics in non-survivors and survivors is provided in Table 1. Compared with patients who survived, non-survivors were more likely to be older and to have higher rates of diabetes and chronic renal failure, higher GRACE scores, lower LVEFs, and more evidence of heart failure (Killip class III or IV). Additionally, patients who died had a significantly lower incidence of baseline TIMI grade 2 or 3 flow (39% vs. 68%; p = 0.005) and a lower final myocardial blush grade (Table 1).
Two patients (0.5%) had a hemorrhagic stroke, 16 (4%) required blood transfusion, and vascular
complications related to the access site were observed in 26 (6.5%) patients. A more detailed
analysis of the vascular access and bleeding complications in patients undergoing pharmacoinvasive
strategy in our institution has been previously reported (1313. Gomes Júnior MPM, Falcão FJA, Alves CMR, Sousa JMA, Herrmann JL,
Moreno ACC, et al. Complicações Vasculares em Pacientes Submetidos a Intervenção
Coronária Percutânea Precoce por Via Femoral após Fibrinólise com Tenecteplase:
Registro de 199 Pacientes. Rev Bras Cardiol Invasiva. 2012;20(3):274-81,
http://dx.doi.org/10.1590/S2179-83972012000300010.
http://dx.doi.org/10.1590/S2179-83972012...
).
Predictors of in-hospital mortality
Based on the multivariate regression analysis, only GRACE score, LVEF, and final blush grade 0-2 were independent predictors of mortality (Table 2).
DISCUSSION
Providing optimal care for STEMI patients is challenging in any country, regardless of its wealth
and developmental level. This is especially true in large urban centers or rural areas, where a lack
of access to tertiary healthcare may make the performance of timely pPCI difficult. The so-called
pharmacoinvasive treatment strategy, consisting of thrombolysis with TNK and contemporary
antithrombotic therapy administered before transport to a PCI-capable hospital, has emerged as an
alternative to pPCI. The recommendation of prompt transfer to a referral center with a
catheterization laboratory is deemed fundamental to the strategy's success, allowing for (i)
immediate reperfusion in cases when thrombolysis fails; (ii) treatment for early reocclusion, which
can affect as many as 30% of cases (1414. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al.
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
N Engl J Med. 2009;360(26):2705-18.); and, ultimately,
(iii) early PCI (<24 hours) for patients with successful thrombolytic reperfusion but with
severe residual stenosis. Compared with pPCI, this strategy has shown similar clinical outcomes
(1515. Bodí V, Rumiz E, Merlos P, Nunez J, López-Lereu MP, Monmeneu JV, et
al. One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy
and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction. Revista
Española de Cardiología. 2011;4(2):111-20,
http://dx.doi.org/10.1016/j.recesp.2010.10.008.
http://dx.doi.org/10.1016/j.recesp.2010....
16. Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, et al.
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary
percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from
the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation.
2008;118(3):268-76, http://dx.doi.org/10.1161/CIRCULATIONAHA.107.762765.
http://dx.doi.org/10.1161/CIRCULATIONAHA...
-1717. Armstrong P. WEST Steering Committee. A comparison of pharmacologic therapy
with/without timely coronary intervention vs primary percutaneous intervention early after
ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction
Therapy) Study. Eur Heart J. 2006;27(13):1530-8,
http://dx.doi.org/10.1093/eurheartj/ehl088.
http://dx.doi.org/10.1093/eurheartj/ehl0...
). Accordingly,
this strategy is strongly recommended by the European Society of Cardiology and ACC/AHA guidelines
(class I and IIa, respectively) (11. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al.
ESC Guidelines for the management of acute myocardial infarction in patients presenting with
ST-segment elevation. Eur Heart J. 2012;33(20):2569-619.,33. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et
al. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary:
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510,
http://dx.doi.org/10.1016/j.jacc.2012.11.018.
http://dx.doi.org/10.1016/j.jacc.2012.11...
).
The present study represents one of the largest real-world studies relevant to this subject thus
far and shows an in-hospital all-cause mortality rate of 5.8%. Other national, multicenter studies
have reported mortality rates of 3.3% in patients who underwent elective PCI after thrombolysis,
7.6% in patients who underwent rescue PCI, and 5.6% in pPCI patients (1818. Lima EC, Nascimento GA, Pena MI, Vasconcelos VSA, Crepaldi RJQ, Rabelo W, et al.
Intervenção Coronária Percutânea Eletiva após Fibrinólise: Dados do
REMAT (Registro Madre Teresa) [Elective Percutaneous Coronary Intervention after Fibrinolysis:
REMAT Data (Madre Teresa Registry)]. Rev Bras Cardiol Invasiva. 2011;19(4):373-8,
http://dx.doi.org/10.1590/S2179-83972011000400007.
http://dx.doi.org/10.1590/S2179-83972011...
,1919. Mattos LA, Sousa AGMR, Pinto IMF, Silva ER, Carneiro JK, Sousa JE, et al. Uma
comparação entre a intervenção coronariana percutânea de resgate e
primária realizadas no infarto agudo do miocárdio: relato multicêntrico de 9.371
pacientes. Arq Bras Cardiol. 2004;82(5):434-9,
http://dx.doi.org/10.1590/S0066-782X2004000500006.
http://dx.doi.org/10.1590/S0066-782X2004...
). In previous randomized multicenter
studies comparing a pharmacoinvasive strategy with ischemia-driven PCI, in-hospital mortality rates
ranged from 3.0% to 4.5%. These studies, however, also demonstrated shorter pain-to-needle and
needle-to-balloon times (2 and 4 hours, respectively), which may explain, at least in part, their
lower mortality rates (1414. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al.
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
N Engl J Med. 2009;360(26):2705-18.,2020. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al.
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the
Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open,
prospective, randomized, multicentre trial. Lancet. 2008;371(9612):559-68,
http://dx.doi.org/10.1016/S0140-6736(08)60268-8.
http://dx.doi.org/10.1016/S0140-6736(08)...
). A remarkably low mortality rate was also observed in a recently published STREAM trial
(2121. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al.
Fibrinolysis or primary PCI in ST-Segment elevation myocardial infarction.
N Engl J Med. 2013;368(15):1379-87.), which compared pPCI with a pharmacoinvasive approach.
This study randomized STEMI patients who had a clinical presentation for less than 3 hours and who
were at least 60 minutes away from pPCI centers and found an overall mortality rate of 4.7% for both
groups. Similar to previous results, such as those obtained in the TRANSFER AMI study (1414. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al.
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
N Engl J Med. 2009;360(26):2705-18.), and our own results, one-third of the STREAM patients required
rescue catheterization.
In the present analysis, LVEF and the GRACE score emerged as significant predictors of mortality. Successful thrombolysis was achieved in over 65% of patients, similar to the rate reported in the STREAM trial, with a mortality rate of only 3.4% in this subgroup (significantly lower than the rate of 10.4% in patients with a baseline TIMI flow of 0-1). Therefore, this study showing a low mortality rate in patients who underwent successful thrombolysis is encouraging and stresses the potential importance of a pharmacoinvasive treatment strategy, especially in public hospitals and developing countries.
Regardless of achieving a similar optimal final TIMI flow after PCI (as a surrogate endpoint for
PCI angiographic success) in both groups, grade 3 myocardial blush was observed significantly less
often in non-survivors; thus, myocardial blush grade was also an important independent predictorof
mortality. Restoring coronary microcirculation through the use of several available strategies and
in light of ongoing studies (e.g., intracoronary abciximab and thrombectomy) has been a challenge
for interventional cardiologists over the last several decades. Studies evaluating patients who
underwent thrombolytic and mechanical reperfusion during STEMI showed a direct relationship between
the degree of myocardial perfusion, as detected by the blush angiographic method, and mortality in
short and long clinical follow-up periods (2222. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical
Implications of the No ‘Reflow' Phenomenon: A Predictor of Complications and Left
Ventricular Remodeling in Reperfused Anterior Wall Myocardial Infarction. Circulation.
1996;93(2):223-8, http://dx.doi.org/10.1161/01.CIR.93.2.223.
http://dx.doi.org/10.1161/01.CIR.93.2.22...
,2323. Henriques JP, Zijlstra L, van ?t Hof AW, de Boer MJ, Dambrink JH, Gosselink M,
et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush
grade. Circulation. 2003;107(16):2115-9,
http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
http://dx.doi.org/10.1161/01.CIR.0000065...
).
Restoring microcirculation extends beyond the restoration of epicardial flow and depends on the
optimization of adjunctive therapy, especially antiplatelet and antithrombotic therapy. Compared
with the STREAM trial population, we achieved similar rates of final TIMI flow 2-3 even in a setting
of a longer pain-to-needle time. Therefore, achieving a baseline TIMI flow of 3 along with a
myocardial blush grade of 3 should be considered to indicate optimal reperfusion. This finding is in
accordance with previous studies demonstrating a normal myocardial blush grade as a predictor of
survival and left ventricular recovery in patients who undergo pPCI and rescue angioplasty (2424. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, et al.
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue
level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial
infarction. Am Heart J. 2004;148(2):336-40,
http://dx.doi.org/10.1016/j.ahj.2003.12.044.
http://dx.doi.org/10.1016/j.ahj.2003.12....
25. Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink
M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush
grade. Circulation. 2003;107(16):2115-9,
http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
http://dx.doi.org/10.1161/01.CIR.0000065...
26. Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, et al.
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty
and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.
J Am Coll Cardiol. 2004;44(2):305-12,
http://dx.doi.org/10.1016/j.jacc.2004.03.058.
http://dx.doi.org/10.1016/j.jacc.2004.03...
27. Di Nucci TP, Pimentel Filho WA, Correia MB, Abdalla Filho R, Bocchi EA, Custodio
WB, et al. Correlação entre o Grau de Perfusão Miocárdica e a Evolução
Clínica Tardia de Pacientes Submetidos a Trombólise e Implante de Stent. Rev Bras Cardiol
Invas. 2006;14(1):56-62.-2828. Bellandi F, Leoncini M, Maioli M, Toso A, Gallopin M, Piero Dabizzi R. Markers
of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial
infarction treated with primary angioplasty. Clinical Cardiology. 2004;27(12):683-8,
http://dx.doi.org/10.1002/clc.4960271205.
http://dx.doi.org/10.1002/clc.4960271205...
).
Hemorrhagic complications are still a concern associated with this strategy. However, no
significant difference was observed in randomized trials between this treatment strategy and other
treatments (1414. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al.
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
N Engl J Med. 2009;360(26):2705-18.,2020. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al.
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the
Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open,
prospective, randomized, multicentre trial. Lancet. 2008;371(9612):559-68,
http://dx.doi.org/10.1016/S0140-6736(08)60268-8.
http://dx.doi.org/10.1016/S0140-6736(08)...
,2121. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al.
Fibrinolysis or primary PCI in ST-Segment elevation myocardial infarction.
N Engl J Med. 2013;368(15):1379-87.). In the STREAM trial, after the amendment of
halving the TNK dosage in patients older than 75 years, there was no significant difference in
hemorrhagic events between the groups. Hemorrhagic stroke and blood transfusion occurred in 0.5% and
2.9% of patients, respectively; in our study, these rates were 0.5% and 4.0%, respectively.
Although far from ideal because pPCI is considered the standard of care for STEMI patients, a pharmacoinvasive treatment strategy could be an alternative for achieving short pain-to-balloon times and, coupled with a structured healthcare network, could represent a highly important improvement in public health management of STEMI in Brazil. The present study is a step forward in adjusting the healthcare system in accordance with global standards to optimally assist the largest possible number of patients.
This study has several limitations. It was an observational and single-center study. A femoral
artery approach was used in all cases, and bleeding criteria may underestimate the actual impact of
this important complication on mortality. In addition, the use of radial access in pPCI has been
associated with lower mortality rates (2929. Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, et al. Radial
versus femoral access for coronary angiography and intervention in patients with acute coronary
syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet. 2011;377(9775):1409-20,
http://dx.doi.org/10.1016/S0140-6736(11)60404-2.
http://dx.doi.org/10.1016/S0140-6736(11)...
,3030. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G,
et al. Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary
Syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute
Coronary Syndrome) Study. J Am Coll Cardiol. 2012;60(24):2481-97,
http://dx.doi.org/10.1016/j.jacc.2012.06.017.
http://dx.doi.org/10.1016/j.jacc.2012.06...
). The multivariate analysis performed in this study cannot
exclude residual confounding due to unmeasured or unknown variables. Finally, the generalizability
of this study is limited because it can only be applied to STEMI patients who undergo a
pharmacoinvasive treatment strategy according to the methods described in our protocol.
In this real-world, prospective study that included STEMI patients who underwent a pharmacoinvasive treatment strategy, in-hospital mortality rates were low at 5.8%. The GRACE score, LVEF, and myocardial blush grade were powerful predictors of mortality after administration of this pharmacoinvasive treatment strategy in the contemporary reperfusion era.
REFERENCES
-
1Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-619.
-
2Piegas LS, Feitosa G, Mattos LA, Nicolau JC, Rossi Neto JM, Timerman A, et al. Sociedade Brasileira de Cardiologia. Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras Cardiol. 2009;93(6 supl.2):e179-e264.
-
3O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et al. ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(4):485-510, http://dx.doi.org/10.1016/j.jacc.2012.11.018.
» http://dx.doi.org/10.1016/j.jacc.2012.11.018 -
4Boden WE, Eagle K, Granger CB. Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction. A Comprehensive Review of Contemporary Management Options. J Am Coll Cardiol. 2007;50(10):917-29, http://dx.doi.org/10.1016/j.jacc.2007.04.084.
» http://dx.doi.org/10.1016/j.jacc.2007.04.084 -
5Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;e574-e651.
-
6Linha do Cuidado do Infarto Agudo do Miocárdio na Rede de Atenção às Urgências [Path of Care of Acute Myocardial Infarction in Emergency Care Networks, guidelines developed by The Brazilian Health Secretary]. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/protocolo_sindrome_coronaria.pdf (Accessed on December 20, 2012).
» http://portal.saude.gov.br/portal/arquivos/pdf/protocolo_sindrome_coronaria.pdf -
7Caluza ACV, Barbosa AH, Gonçalves I, Oliveira CAL, Matos LN, Zeefried C, et al. Rede de Infarto com Supradesnivelamento de ST: Sistematização em 205 Casos Diminui Eventos Clínicos na Rede Pública [ST-Elevation Myocardial Infarction Network: Systematization in 205 Cases Reduces Clinical Events in the Public Health Care System]. Arq Bras Cardiol. 2012;99(5):1040-8, http://dx.doi.org/10.1590/S0066-782X2012005000100.
» http://dx.doi.org/10.1590/S0066-782X2012005000100 -
8TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932-6.
-
9van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97(23):2302-6, http://dx.doi.org/10.1161/01.CIR.97.23.2302.
» http://dx.doi.org/10.1161/01.CIR.97.23.2302 -
10Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41, http://dx.doi.org/10.1159/000180580.
» http://dx.doi.org/10.1159/000180580 -
11WHO. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1). Available at: http://www.who.int/vmnis/indicators/haemoglobin.pdf (Accessed on December 20, 2012).
» http://www.who.int/vmnis/indicators/haemoglobin.pdf -
12Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53, http://dx.doi.org/10.1001/archinte.163.19.2345.
» http://dx.doi.org/10.1001/archinte.163.19.2345 -
13Gomes Júnior MPM, Falcão FJA, Alves CMR, Sousa JMA, Herrmann JL, Moreno ACC, et al. Complicações Vasculares em Pacientes Submetidos a Intervenção Coronária Percutânea Precoce por Via Femoral após Fibrinólise com Tenecteplase: Registro de 199 Pacientes. Rev Bras Cardiol Invasiva. 2012;20(3):274-81, http://dx.doi.org/10.1590/S2179-83972012000300010.
» http://dx.doi.org/10.1590/S2179-83972012000300010 -
14Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360(26):2705-18.
-
15Bodí V, Rumiz E, Merlos P, Nunez J, López-Lereu MP, Monmeneu JV, et al. One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction. Revista Española de Cardiología. 2011;4(2):111-20, http://dx.doi.org/10.1016/j.recesp.2010.10.008.
» http://dx.doi.org/10.1016/j.recesp.2010.10.008 -
16Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation. 2008;118(3):268-76, http://dx.doi.org/10.1161/CIRCULATIONAHA.107.762765.
» http://dx.doi.org/10.1161/CIRCULATIONAHA.107.762765 -
17Armstrong P. WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) Study. Eur Heart J. 2006;27(13):1530-8, http://dx.doi.org/10.1093/eurheartj/ehl088.
» http://dx.doi.org/10.1093/eurheartj/ehl088 -
18Lima EC, Nascimento GA, Pena MI, Vasconcelos VSA, Crepaldi RJQ, Rabelo W, et al. Intervenção Coronária Percutânea Eletiva após Fibrinólise: Dados do REMAT (Registro Madre Teresa) [Elective Percutaneous Coronary Intervention after Fibrinolysis: REMAT Data (Madre Teresa Registry)]. Rev Bras Cardiol Invasiva. 2011;19(4):373-8, http://dx.doi.org/10.1590/S2179-83972011000400007.
» http://dx.doi.org/10.1590/S2179-83972011000400007 -
19Mattos LA, Sousa AGMR, Pinto IMF, Silva ER, Carneiro JK, Sousa JE, et al. Uma comparação entre a intervenção coronariana percutânea de resgate e primária realizadas no infarto agudo do miocárdio: relato multicêntrico de 9.371 pacientes. Arq Bras Cardiol. 2004;82(5):434-9, http://dx.doi.org/10.1590/S0066-782X2004000500006.
» http://dx.doi.org/10.1590/S0066-782X2004000500006 -
20Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomized, multicentre trial. Lancet. 2008;371(9612):559-68, http://dx.doi.org/10.1016/S0140-6736(08)60268-8.
» http://dx.doi.org/10.1016/S0140-6736(08)60268-8 -
21Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, et al. Fibrinolysis or primary PCI in ST-Segment elevation myocardial infarction. N Engl J Med. 2013;368(15):1379-87.
-
22Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical Implications of the No ‘Reflow' Phenomenon: A Predictor of Complications and Left Ventricular Remodeling in Reperfused Anterior Wall Myocardial Infarction. Circulation. 1996;93(2):223-8, http://dx.doi.org/10.1161/01.CIR.93.2.223.
» http://dx.doi.org/10.1161/01.CIR.93.2.223 -
23Henriques JP, Zijlstra L, van ?t Hof AW, de Boer MJ, Dambrink JH, Gosselink M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115-9, http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
» http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED -
24Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, et al. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. 2004;148(2):336-40, http://dx.doi.org/10.1016/j.ahj.2003.12.044.
» http://dx.doi.org/10.1016/j.ahj.2003.12.044 -
25Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003;107(16):2115-9, http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED.
» http://dx.doi.org/10.1161/01.CIR.0000065221.06430.ED -
26Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol. 2004;44(2):305-12, http://dx.doi.org/10.1016/j.jacc.2004.03.058.
» http://dx.doi.org/10.1016/j.jacc.2004.03.058 -
27Di Nucci TP, Pimentel Filho WA, Correia MB, Abdalla Filho R, Bocchi EA, Custodio WB, et al. Correlação entre o Grau de Perfusão Miocárdica e a Evolução Clínica Tardia de Pacientes Submetidos a Trombólise e Implante de Stent. Rev Bras Cardiol Invas. 2006;14(1):56-62.
-
28Bellandi F, Leoncini M, Maioli M, Toso A, Gallopin M, Piero Dabizzi R. Markers of myocardial reperfusion as predictors of left ventricular function recovery in acute myocardial infarction treated with primary angioplasty. Clinical Cardiology. 2004;27(12):683-8, http://dx.doi.org/10.1002/clc.4960271205.
» http://dx.doi.org/10.1002/clc.4960271205 -
29Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet. 2011;377(9775):1409-20, http://dx.doi.org/10.1016/S0140-6736(11)60404-2.
» http://dx.doi.org/10.1016/S0140-6736(11)60404-2 -
30Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, et al. Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2012;60(24):2481-97, http://dx.doi.org/10.1016/j.jacc.2012.06.017.
» http://dx.doi.org/10.1016/j.jacc.2012.06.017
-
No potential conflict of interest was reported.
Publication Dates
-
Publication in this collection
Dec 2013
History
-
Received
18 Apr 2013 -
Reviewed
22 May 2013 -
Accepted
20 June 2013